Amgen’s Mvasi is a biosimilar of Genentech’s Avastin
News
Number of written complaints about NHS increases 4.9 per cent
208,400 written complaints received during 2016/17
Cardiovascular outcomes dominate EASD
Promising new results from Novo, Lilly, Boehringer and Janssen
AstraZeneca to divest remaining anaesthetics portfolio rights
Rights will be sold to Aspen in $766 million deal
Abbott’s flash glucose monitor to be made available on NHS
FreeStyle Libre allows patients to monitor glucose without the need for pricking
FDA grants fast-track designation for Shire’s lung drug
SHP607 targets chronic lung disease in premature infants
ESMO news – 13 September
New results from BMS and Pfizer
Humira gets EC approval for anterior uveitis
Humira is now the only EU biologic treatment option for children with the disease
Conference round-up: ERS and ESMO
News from the European Respiratory Society and European Society for Medical Oncology congresses
Prix Galien opens for entries with new award
2018 Awards will include an new category for Medical Technology, alongside accolades for Innovative Products, Orphan Products and Real World Evidence.
SMC accepts 4 new medicines
Approvals for Lilly, BMS, TESARO and Alan Pharmaceuticals
New migraine results for both Allergan and Novartis
New data presented for Allergan’s Botox and Novartis’ erenumab
Merck to co-lead Big Data alliance
Firm will partner with Project Data Sphere
ESMO roundup – 11 September
Renal cell carcinoma results dominate
Roche blood test can accurately predict immunotherapy efficacy
Test measures tumour mutations to show which patients respond best to certain immunotherapies
